■ Published papers
|
Original article
|
|
1.
|
Guntulu Ak†, Yuji Tada†, Hideaki Shimada, Selma Metintas, Masaaki Ito, Kenzo Hiroshima,
Masatoshi Tagawa*, Muzaffer Metintas*：
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin.
BMC cancer
17
：212
, 2017.3
DOI:10.1186/s12885-017-3209-5
|
|
2.
|
Shoutaro Tsuji†, Kota Washimi, Taihei Kageyama, Makiko Yamashita, Mitsuyo Yoshihara, Rieko Matsuura, Tomoyuki Yokose, Yoichi Kameda, Hiroyuki Hayashi, Takao Morohoshi, Yukio Tsuura, Toshikazu Yusa, Takashi Sato, Akira Togayachi, Hisashi Narimatsu, Toshinori Nagasaki, Kotaro Nakamoto, Yasuhiro Moriwaki, Hidemi Misawa, Kenzo Hiroshima, Yohei Miyagi, Kohzoh Imai1：
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.
Scientific Reports
7
：45768
, 2017.3
DOI:10.1038/srep45768
|
|
3.
|
Di Wu†, Kenzo Hiroshima*, Toshikazu Yusa, Daisuke Ozaki, eitetsu koh, Yasuo Sekine, Shinji Matsumoto, Kazuki Nabeshima, Ayuko Sato, Tohru Tsujimura, Hisami Yamakawa, Yuji Tada, Hideaki Shimada, Masatoshi Tagawa：
Usefulness of p16/CDKN2A FISH and BAP1 Immunohistochemistry for the Diagnosis of Biphasic Mesothelioma.
Annals of diagnostic pathology
26
：31-37
, 2017.2
DOI:10.1016/j.anndiagpath.
|
|
4.
|
Nakano Masayuki†*, Ariizumi Shunichi, Yamamoto Masakazu：
Intrahepatic cholangiocarcinoma.
Seminars in diagnostic pathology
34
(2)
：160-166
, 2017.2
DOI:10.1053/j.semdp.2016.12.012.
|
|
5.
|
Thunnissen E†, Borczuk AC, Flieder DB, Witte B, Beasley MB, Chung JH, Dacic S, Lantuejoul S, Russell PA, den Bakker M, Botling J, Brambilla E, de Cuba E, Geisinger K, Hiroshima K, Marchevsky A, Minami Y, Moreira A, Nicholson AG, Yoshida A, Tsao MS, Warth A, Duhig E, Chen G, Matsuno Y, Travis WD, Butnor K, Cooper W, Mino-Kenudson M, Motoi N, Poleri C, Pelosi G, Kerr K, Aisner SC, Ishikawa Y, Buettner RH, Keino N, Yatabe Y, Noguchi M.：
The use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and its Differential Diagnosis. An international reproducibility study in a demanding set of cases.
Journal of Thoracic Oncology
12
(2)
：334-346
, 2016.12
DOI:10.1016/j.jtho.2016.12.004
|
|
6.
|
Masunaga Atsuko†*, Hayashi Shoko, Omatsu Mutsuko, Kunimura Toshiaki, Suzuki Kousuke, Uematsu Shugo, Kitami Akihiko, Oide Takashi, Miyagi Yohei, Hiroshima Kenzo, Suzuki Takashi：
Six candidate proneural factor essenger RNAs for the differentiation of neuroendocrine and non-neuroendocrine carcinomas of the lung.
Journal of Clinical and Experimental Pathology
6
(5)
：1000292
, 2016.9
DOI:10.4172/2161-0681.1000292
|
|
7.
|
Hamasaki M†, Matsumoto S, Abe S, Hamatake D, Kamei T, Hiroshima K, Kawahara K, Sato A, Tsujimura T, Nakatani Y, Yoshida Y, Iwasaki A, Nabeshima K.：
Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands)
99
：155-161
, 2016.9
DOI:10.1016/j.lungcan.2016.07.011.
|
|
8.
|
Kawai T†, Tominaga S, Hiroi S, Ogata S, Nakanishi K, Kawahara K, Sonobe H, Hiroshima K.：
Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Journal of clinical pathology
69
(8)
：706-712
, 2016.8
DOI:10.1136/jclinpath-2015-203211
|
|
9.
|
Jiang Y†, Zhong B, Kawamura K, Morinaga T, Shingyoji M, Sekine I, Tada Y, Tatsumi K, Shimada H, Hiroshima K, Tagawa M.：
Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma.
BMC cancer
16
(1)
：455
, 2016.7
DOI:10.1186/s12885-016-2483-y
|
|
10.
|
Kenzo Hiroshima†*, Di Wu, Mizue Hasegawa,Eitetsu Koh, Yasuo Sekine, Daisuke Ozaki, Toshikazu Yusa, Ann E. Walts, Alberto M. Marchevsky, Kazuki Nabeshima,Yuji Tada, Hideaki Shimada, Masatoshi Tagawa：
Cytologic Differential Diagnosis of Malignant Mesothelioma and Reactive Mesothelial Cells with FISH Analysis of p16.
Diagnostic cytopathology
44
(7)
：591-598
, 2016.7
DOI:10.1002/dc.23490
|
|
11.
|
Ann E. Walts†*, Kenzo Hiroshima, Stephanie M. McGregor, Di Wu, Aliya N. Husain, Alberto M. Marchevsky：
BAP1 immunostain and CDKN2A (p16) FISH analysis: Clinical applicability for the diagnosis of malignant mesothelioma in effusions.
Diagnostic cytopathology
44
(7)
：599-606
, 2016.7
DOI:10.1002/dc.23491
|
|
12.
|
Iwata T†, Yoshino I, Yoshida S, Ikeda N, Tsuboi M, Asato Y, Katakami N, Sakamoto K, Yamashita Y, Okami J, Mitsudomi T, Yamashita M, Yokouchi H, Okubo K, Okada M, Takenoyama M, Chida M, Tomii K, Matsuura M, Azuma A, Iwasawa T, Kuwano K, Sakai S, Hiroshima K, Fukuoka J, Yoshimura K, Tada H, Nakagawa K, Nakanishi Y; West Japan Oncology Group.：
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Respiratory research
17
(1)
：90
, 2016.7
DOI:10.1186/s12931-016-0398-4
|
|
13.
|
由佐俊和†, 安川朋久, 塩田広宣, 千代雅子, 佐田諭己, 廣島健三：
石綿関連肺癌の頻度と臨床像に関する検討―原発性肺癌の連続479手術例を対象として―.
肺癌
56
(2)
：90-97
, 2016.5
|
|
Display 5 items
|
|
Display all(13)
|
|
Review article
|
|
1.
|
中野雅行†*：
【肝臓I:肝病理診断のポイント-びまん性肝疾患-】 急性肝炎と慢性肝炎の病理学的鑑別.
病理と臨床
35
(5)
：214-217
, 2017.3
|
|
2.
|
佐藤之俊, 廣島健三, 伊豫田明, 薄田勝男, 大林千穂, 河原邦光, 斎藤泰紀, 佐藤雅美, 武島幸男, 蔦幸治, 羽場礼次, 三浦弘之, 吉澤明彦, 宝来威, 遠藤千顕, 柿沼廣邦, 竹中明美, 三宅真司.：
細胞診.
日本肺癌学会編. 臨床・病理 肺癌取扱い規約 第8版
：125-148
, 2017.1
|
|
3.
|
大林千穂, 谷田部恭, 武島幸男, 蔦幸治, 鍋島一樹, 仁木利郎, 野口雅之, 東山聖彦, 松野吉宏, 元井紀子, 吉澤明彦, 石川雄一, 石井源一郎, 岡本賢三, 河原邦光, 酒井康裕, 佐藤之俊, 田口健一, 中谷行雄, 林雄一郎, 廣島健三, 南優子.：
病理診断.
日本肺癌学会編. 臨床・病理 肺癌取扱い規約 第8版
：67-124
, 2017.1
|
|
4.
|
廣島健三†*：
悪性中皮腫の病理診断.
日本婦人科病理学
7
(2)
：35-37
, 2016.11
|
|
5.
|
廣島健三†*：
悪性中皮腫の病理診断.
病理と臨床
34
(4)
：356-362
, 2016.4
|
|
6.
|
Kazuki Nabeshima†, Shinji Matsumoto, Makoto Hamasaki, Tomoyuki Hida, Toshiaki Kamei, Kenzo Hiroshima, Tohru Tsujimura, and Kunimitsu Kawahara：
Use of p16 FISH for Differential Diagnosis of Mesothelioma in Smear Preparations.
Diagnostic cytopathology
44
(9)
：774-780
, 2016.4
DOI:10.1002/dc.23501
|
|
Display 5 items
|
|
Display all(6)
|
|
Case report
|
|
1.
|
Oide T†*, Hiroshima K, Takahashi Y, Fugo K, Yamatoji M, Kasamatsu A, Endo-Sakamoto Y, Shiiba M, Uzawa K, Tanzawa H, Nagao T, Nakatani Y：
Mucoepidermoid carcinoma with extensive spindled morphology and melanocytic marker expression.
Human pathology
*
：*
, 2017.3
|
|
2.
|
Takahide Toyoda†, Atsuko Masunaga, Mitsutoshi Shiba, Kenzo Hiroshima*：
An atypical type A thymoma with lung invasion and pleural metastasis: A case report.
Human pathology
3
：46-50
, 2017.3
|
|
3.
|
Oide T†*, Hiroshima K, Shibuya K, Nakatani Y：
Primary pulmonary meningioma presenting as a coin lesion.
Internal Medicine
*
：*
, 2017.3
|
|
4.
|
Oide T†, Kan M, Masunaga A, Nishino T, Hiroshima K：
Histopathology of immature (ongoing) squamous metaplasia of the stomach.
Pathology International
*
：*
, 2017.2
DOI:10.1111/pin.12636
|
|
5.
|
Yokohori N†, Sato A, Hasegawa M, Katsura H, Hiroshima K, Takemura T.：
Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA).
Internal Medicine
56
(1)
：73-78
, 2017.1
DOI:10.2169/internalmedicine
|
|
6.
|
Shimizu S†, Yoon HE, Ito N, Tsuji T, Funakoshi Y, Utsumi T, Sakaguchi M, Tsujimura T, Kasai T, Hiroshima K, Matsumura A.：
A Case of Solitary Well-Differentiated Papillary Mesothelioma with Invasive Foci in the Pleura.
Pathology International
67
(1)
：45-49
, 2017.1
DOI:10.1111/pin.12483
|
|
7.
|
Ito H†, Kamei T, Odake S, Nakano M, Okeda R, Kohriki S, Kawachi J, Onders RP, Yoshii F：
An Autopsy Case of Amyotrophic Lateral Sclerosis with Diaphragm Pacing.
Internal Medicine
55
(53)
：3511-3513
, 2016.12
|
|
8.
|
Furuya Y†, Hiroshima K, Wakahara T, Akimoto H, Yanagie H, Harigaya K, Yasuhara H.：
Undifferentiated carcinoma of the gallbladder with endothelial differentiation: A case report and literature review.
Molecular and Clinical Oncology
5
(6)
：773-776
, 2016.12
DOI:10.3892/mco.2016.1046.
|
|
9.
|
中野雅行†*：
HBV既往感染の肝硬変に多発した良性、悪性肝細胞腫瘍のHE、VB標本による簡易診断.
Liver Cancer
22
：75-79
, 2016.11
|
|
10.
|
Oide T†*, Yasufuku K, Shibuya K, Yoshino I, Nakatani Y, Hiroshima K：
Primary pulmonary glomus tumor of uncertain malignant potential: A case report with literature review focusing on current concepts of malignancy grade estimation.
Respiratory Medicine Case Reports
19
：143-149
, 2016.10
DOI:10.1016/j.rmcr.2016.10.002
|
|
11.
|
渥實潤†, 菅野雅之, 清水雄至, 茂木充, 田中優子, 宮永朋実, 小川晃, 廣島健三：
肺原発lymphoepithelioma-like carcinomaおよび組織学的に類似した肺癌.
肺癌
56
(2)
：130-131
, 2016.5
|
|
12.
|
吉田和史†, 南優子, 薄井真悟, 島内正起, 林原賢治, 蔵本健矢, 兵頭健太郎, 根本健司, 大石修司, 齋藤武文, 廣島 健三：
気管支上皮内進展を来しポリープ様に認められた大細胞神経内分泌癌の1例.
肺癌
56
(2)
：132-133
, 2016.5
|
|
13.
|
芳野充†, 関根康雄, 黄英哲, 長谷川瑞江, 廣島健三：
導入化学療法後に手術を施行し，肺結核合併と診断された肺癌の1例.
肺癌
56
(2)
：114-118
, 2016.4
|
|
Display 5 items
|
|
Display all(13)
|
|
To the top
|
|
■ Academic conference presentation
|
1.
|
◎Yoshiaki Kinoshita, Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto, Tohru Tsujimura, Kunimitsu
Kawahara, Kenzo Hiroshima, Yoshinao Oda, Kazuki Nabeshima：
A Combination of MTAP and BAP1 Immunohistochemistry Is Useful for Differentiating Malignant and Benign Mesothelial Proliferatons in Tissue and Cytological Specimen.
2017 USCAP Annual Meeting,
San Antonio, USA,
2017/03
|
|
2.
|
◎Lauren E Rosen, Vijayalakshmi Ananthanarayanan, Alexander Gallan, Melissa Yuwono Tjota, Richard
Attanoos, Fouad S Alchami, Luka Brcic, Kelly Butnor, Kenzo Hiroshima, Astero Klampatsa, Leslie Litzky,
Alberto M Marchevsky, Filomena Medeiros, M Angeles Montero-Fernandez, David A Moore, Kazuki Nabeshima, Elizabeth N Pavlisko, Anupama Sharma, Michael Sheaff, Ann E Walts, Francoise Galateau,
Nolwenn Le Stang, Thomas Krausz, Aliya N Husain：
Nuclear Grade, Necrosis and Solid Growth Pattern Predict Survival in Epithelioid Malignant Mesothelioma: An International, Multi-Institutional Study.
2017 USCAP Annual Meeting,
San Antonio, USA,
2017/03
|
|
3.
|
◎Andrew Nicholson, Patrizia Viola, Kathleen Torkko, Edwina Duhig, Kim Geisinger, Alain Borczuk, Kenzo Hiroshima, Ming Tsao, Arne Warth, Sylvie Lantuejoul, Prudence Russell, Erik Thunnissen, Alberto Marchevsky, Mari Mino-Kenudson, Mary Beth Beasley, Johan Botling, Sanja Dacic, Yasushi Yatabe, Masayuki Noguchi, William Travis, Keith Kerr, Fred R. Hirsch, Lucian Chirieac, Ignacio Wistuba, Andre Moreira, Jin-Haeng Chung, Teh Ying Chou, Lukas Bubendorf, Gang Chen, Giuseppe Pelosi, Claudia Poleri, Wilbur Franklin：
REPRODUCIBILITY OF COMPREHENSIVE HISTOLOGIC ASSESSMENT AND REFINING HISTOLOGIC CRITERIA IN P STAGING OF MULTIPLE TUMOUR NODULES.
IASLC 17th World Conference on Lung Cancer,
Vienna, Austria,
2016/12
|
|
4.
|
◎Kenzo Hiroshima, Di Wu, Yasuo Sekine, Daisuke Ozaki, Toshikazu Yusa, Kouta Washimi, Reiji Haba, Yuji Tada, Hideaki Shimada, Masatoshi Tagawa：
BAP1 immunostaining and FISH analysis of p16 help making distinction among subtypes of mesotheliomas.
IASLC 17th World Conference on Lung Cancer,
Vienna, Austria,
2016/12
|
|
5.
|
◎Masatoshi Tagawa, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima：
Preclinical and clinical researches for malignant mesothelioma with gene medicine and bisphosphonates.
International Society for Cell and Gene Therapy of Cancer,
Seoul, Korea,
2016/11
|
|
6.
|
◎Yuji Tada, Nguyen Thanh Thao, Shuji Kubo, Masato Shingyoji, Ikuo Sekine, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima,Masatoshi Tagawa：
E1B-55kDa-defective adenoviruses produced cytotoxicity in combination with MDM2 inhibitors on INK4A/ARF-defective mesothelioma.
European Society of Gene and Cell Therapy 2016,
Florence,
2016/10
|
|
7.
|
◎Oide Takashi, Hiroshima Kenzo, Yamatoji Masanobu, Takahashi Yoko, Fugo Kazunori, Kasamatsu Atsushi, Endo-Sakamoto Yosuke, Shiiba Masashi, Uzawa Katsuhiro, Tanzawa Hideki, Nagao Toshitaka, Nakatani Yukio：
A case of mucoepidermoid carcinoma with extensive spindle cell differentiation expressing melanocytic markers.
The 6th Japan-Taiwan Conjoint Slide Conference,
Nagoya, Japan,
2016/10
|
|
8.
|
◎Kazuo Kase, Nobuko Saito, Yuji Sato, Kenzo Hiroshima, Yukari Okita, Yukihide Watanabe, Hiroyuki Suzuki, Mituyasu Kato：
Three dimensional imaging analysis of the promotion process froma BCAC to colonic adenomas.
The 32nd World Congress of Biomedical Laboratory Science,
Kobe,
2016/09
|
|
9.
|
◎Toshiaki Kamei, Hidemi Shibuta, Kaori Yasunaga, Sakae Hata, Shinji Hamakawa, Kazuki Nabeshima, Shinji Matsumoto, Teruaki Oka, Kenzo Hiroshima, Tohru Tsujimura：
Cytomorphological significance in diagnosing malignant mesothelioma in serous effusions.
The 19th International Congress of Cytology,
Yokohama,
2016/06
|
|
10.
|
◎Kenzo Hiroshima, Di Wu, Mizue Hasegawa, Eitetsu Koh, Yasuo Sekine, Daisuke Ozaki, Toshikazu Yusa, Ann E. Walts, Alberto M. Marchevsky：
Utility of p16/CDKN2A FISH and BAP1 immunohistochemistry in Distinguishing between Mesothelioma and Reactive Mesothelial Proliferation.
The 19th International Congress of Cytology,
Yokohama,
2016/05
|
|
11.
|
◎Masatoshi Tagawa, Shinya Okamoto, Takao Morinaga, Masato Shingyoji, Ikuo Sekine, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima：
Combination of nutlin-3a and HSP90 inhibitors produces synergistic cytotxicity on mesothelioma with the wild-type p53.
13th International Conference of the International Mesothelioma Group (iMig 2016),
Birmingham,
2016/05
|
|
12.
|
◎Yuji Tada, Takao Morinaga, Toshio Suzuki, Hideaki Shimada, Koichiro Tatsumi, Kenzo Hiroshima, Masatoshi Tagawa：
ANTI-TUMOR EFFECTS OF METFORMIN AND NUTLIN-3A IN MALIGNANT PLEURAL MESOTHELIOMA.
13th International Conference of the International Mesothelioma Group (iMig 2016),
Birmingham,
2016/05
|
|
13.
|
◎Alexander J. Gallan, Viju Ananthanarayanan, Kenzo Hiroshima, Alberto Marchevsky, Stephanie Mcgregor, Angeles Montero, Kazuki Nabeshima, Wickii Vigneswaran, Ann Walts, Thomas Krausz, Aliya Husain：
NECROSIS AND SOLID GROWTH PATTERN AUGMENT NUCLEAR GRADING IN PREDICTING SURVIVAL IN EPITHELIOID MALIGNANT MESOTHELIOMA.
13th International Conference of the International Mesothelioma Group (iMig 2016),
Birmingham,
2016/05
|
|
14.
|
◎Kenzo Hiroshima, Di Wu, Mizue Hasegawa, Yasuo Sekine, Daisuke Ozaki, Toshikazu Yusa, Zhi bin Gao, Yuji Tada, Hideaki Shimada, Masatoshi Tagawa：
Utility of BAP1 immunohistochemistry and FISH in the differential diagnosis of malignant mesothelioma.
13th International Conference of the International Mesothelioma Group (iMig 2016),
Birmingham,
2016/05
|
|
15.
|
◎Mizue Hasegawa, Asako Okabayashi, Akitoshi Sato, Naoko Yokohori, Hideki Katsura, Toshiko Kamata, Eitetsu Koh, Yasuo Sekine, Di Wu, Kenzo Hiroshima：
SLOWLY PROGRESSIVE MALIGNANT PLEURAL MESOTHELIOMA IN AGED PATIENTS.
13th International Conference of the International Mesothelioma Group (iMig 2016),
Birmingham,
2016/05
|
|
16.
|
◎Masatoshi Tagawa, Takao Morinaga, Zhihan Li, Thao T. T. Nguyen, Boya Zhong, Shuji Kubo, Ikuo Sekine, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima：
Combination of Forced Transduction of P53 and an Agent That Blocks MDM2p53
Interactions Produces Synergistic Cytotoxicity on Mesothelioma Defective of the INK4A/ARF Region.
ASGCT 19th,
Washington, DC,
2016/05
|
|
17.
|
◎廣島健三：
肺癌および中皮腫の新WHO病理分類.
第四回城南地区呼吸器外科研究会,
東京,
2017/03
|
|
18.
|
◎増永敦子, 大出貴士, 廣島健三, 斎藤直, 乾政志：
膀胱に多発したparagangliomaの一例.
第７４回病理学会関東支部会,
横浜, 日本,
2017/03
|
|
19.
|
◎豊田行英, 増永敦子, 藤原大樹, , 飯田智彦, 柴 光年, 吉野一郎, 廣島健三：
肺浸潤、胸膜播種を呈したatypical type A thymomaの1例.
第 36 回日本胸腺研究会,
京都,
2017/02
|
|
20.
|
◎塩田広宣, 安川朋久, 千代雅子, 守屋康充, 由佐俊和, 外山真一, 弥富真理, 山本司, 國友史雄, 廣島健三：
長期生存が得られている末端肥大症に合併したEGFR 遺伝子変異陽性IVa 期肺腺癌の1 例.
第57回日本肺癌学会学術集会,
福岡,
2016/12
|
|
21.
|
◎高橋昌樹, 今野辰郎, 末澤亜紀, 角奈美子, 南部周平, 地曳典恵, 清水忠夫, 大出貴士, 増永敦子, 廣島健三：
乳癌センチネルリンパ節捺印細胞診の細胞像と有用性.
第55回日本臨床細胞学会秋期大会,
大分,
2016/11
|
|
22.
|
◎佐藤祐美穂, 折笠英紀, 山口ゆかり, 真嶋恵子, 中原万里子, 森永正二郎, 山本智子, 廣島健三：
多形型腹膜悪性中皮腫の一例.
第55回日本臨床細胞学会秋期大会,
大分,
2016/11
|
|
23.
|
◎廣島健三：
肺癌取扱い規約細胞判定基準の改訂 悪性胸膜中皮腫の細胞診.
第55回日本臨床細胞学会秋期大会,
大分,
2016/11
|
|
24.
|
◎木村伯子, 廣島健三：
悪性中皮腫ラブドイド型の一剖検例.
第55回日本臨床細胞学会秋期大会,
大分,
2016/11
|
|
25.
|
◎廣島健三：
中皮腫の病理診断の最前線.
中皮腫シンポジウム 悪性胸膜中皮腫の診断/治療の最前線,
西宮,
2016/10
|
|
26.
|
◎廣島健三：
増え続ける悪性胸膜中皮腫 ～病理診断の困難さ～.
新潟県臨床検査技師会 平成28年度病理細胞部門研修会,
新潟,
2016/10
|
|
27.
|
◎多田裕司, ◎廣島健三, 塩田広宣, 安川朋久, 尾崎大介, 由佐俊和：
症例23-03.
第23回中皮腫パネル,
広島,
2016/10
|
|
28.
|
◎田川雅敏, 盛永敬郎, 钟博雅, Nguyen Thi Thanh Thao, 久保秀司, 関根郁夫, 多田裕司, 巽浩一郎, 島田英昭, 廣島健三：
MDMX阻害剤の悪性中皮腫に対する細胞傷害活性はp53非依存的であるが、MDM2阻害剤とは相乗的な併用効果を示す.
第75回日本癌学会,
横浜,
2016/10
|
|
29.
|
◎廣島健三：
胸膜中皮腫のWHO新分類.
第11回中皮腫細胞診セミナ－,
仙台,
2016/09
|
|
30.
|
◎呉迪，廣島健三，長谷川瑞江，黄英哲，関根康雄，高志斌，羽場礼次，鷲見公太, 尾崎大介，由佐俊和：
BAP1の発現及び欠失による中皮腫と反応性中皮の鑑別.
第7回JMIG研究会,
名古屋,
2016/09
|
|
31.
|
◎黄英哲, 鎌田稔子, 関根康雄, 岡林麻子, 長谷川瑞江, 桂秀樹, 廣島健三：
当院での肺がん術後再発に対してニボルマブを投与した３例の検討.
第176回日本肺癌学会関東支部会,
新宿,
2016/07
|
|
32.
|
◎Masatoshi Tagawa, Taka-aki Kozono, Yiyang Qin, Xue Rao Ning, Takao Morinaga, Shuji Kubo, Masato Shingyoji, Ikuo Sekine, Yuji Tada, Koichiro Tatsumi, Hideaki Shimada, Kenzo Hiroshima：
MDM2 and MDM4 inhibitors in combination with adenoviruses up-regulating p53 produce synergistic anti-tumor effects on mesothelioma through augmenting apoptotic processes.
第21回日本遺伝子治療学会学術集会,
大阪,
2016/07
|
|
33.
|
◎廣島健三：
悪性中皮腫の病理診断.
第44回日本婦人科病理学会学術集会,
東京,
2016/06
|
|
34.
|
◎鎌倉靖夫, 細沼佑介, 細沼沙紀, 中村勝, 瀬山敦, 榊美佳, 清水禎彦, 廣島健三, 新井栄一, 安田政実：
胸膜肺芽腫の一例.
第57回日本臨床細胞学会総会（春期大会）,
横浜,
2016/05
|
|
35.
|
◎角奈美子, 今野辰郎, 高橋昌樹, 末澤亜紀, 南部周平, 黄英哲, 関根康雄, 増永敦子, 廣島健三：
手術捺印標本における肺腺癌及び扁平上皮癌の細胞像.
第57回日本臨床細胞学会総会（春期大会）,
横浜,
2016/05
|
|
36.
|
◎畠榮, 亀井敏昭, 渋田秀美, 濱川真治, 岡輝明, 廣島健三, 辻村亨, 松本慎二, 鍋島一樹, 丸川活司：
悪性中皮腫における印環細胞の診断的意義に対する考察.
第57回日本臨床細胞学会総会（春期大会）,
横浜,
2016/05
|
|
37.
|
◎鈴木友里絵, 五十嵐昭喜, 須賀道恵, 飯塚英治, 河村俊治, 相羽元彦, 藤林真理子, 廣島健三：
右頸部〜鎖骨上リンパ節転移を示した悪性腹膜中皮腫の1例.
第57回日本臨床細胞学会総会（春期大会）,
横浜,
2016/05
|
|
38.
|
◎原田直, 太田聡, 鈴木理樹, 岩本雅美, 塙真輔, 三橋暁, 生水真紀夫, 廣島健三, 中谷行雄：
高悪性度の子宮肉腫で、ALK陽性により炎症性筋線維芽細胞腫瘍と診断した一例.
第105 回日本病理学会総会,
仙台,
2016/05
|
|
39.
|
◎廣島健三，呉迪，長谷川瑞江，黄英哲，関根康雄，高 志斌，羽場礼次，尾崎大介，由佐俊和：
BAP1による中皮腫と反応性中皮の鑑別.
第105回日本病理学会総会,
仙台,
2016/05
|
|
40.
|
◎高山智裕, 齋藤直, 土岐大介, 瀬戸口誠, 廣島健三, 乾政志：
内分泌療法中に扁平上皮癌化したPSA低値、CA19-9高値の前立腺癌の1例.
第104回日本泌尿器科学会総会,
仙台,
2016/04
|
|
41.
|
◎増永敦子, 大出貴士, 廣島健三, 兒玉聖子, 浅野千尋, 増田道彦：
反応性好酸球増多症の一例.
第９回東京骨髄病理研究会,
東京, 日本,
2017/03
|
|
42.
|
◎廣島健三：
石綿（アスベスト）の健康影響や被害について.
千葉県平成２８年度 （石綿アスベスト）健康診断・治療従事者及び相談業務担当者研修会,
千葉,
2016/11
|
|
Display 5 items
|
|
Display all(42)
|
|
To the top
|
|
